4-Prop-2-ynyl-thiomorpholine 1,1-dioxide, 95.0%, 10g

(R)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine>98.0%(GC)5g

9H-Fluoren-2-ol, 98%, 1g

5-Hydroxy-2-methyl-[1,4]naphthoquinone, 95.0%, 1g

2,3,4,4'-Tetrahydroxydiphenylmethane>95.0%(GC)5g

Benzo[g]quinoxaline, 98%, 1g

2-Acetoxy-2',6'-methoxybenzophenone, 90.0%, 1g

GC capillary column ROTI®Cap-5, 15 m, 0.32 mm, 0.10 µm, 1 Piece(s)

tert-Butyl (1-benzhydrylazetidin-3-yl)carbamate, 95.0%, 250mg

3,6,9,12-Tetraoxatetradecanoic acid, 14-amino-, 1,1-dimethylethylester, 97%, 100mg

2-Phenoxy-1-phenylpropan-1-ol, 98.0%, 1g

2-Amino-5-bromobenzamide, 97.0%, 1g

4,4'-Sulfonylbis-morpholine, 100mg